about
FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cellsDown-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisSolution structure and backbone dynamics of the DNA-binding domain of FOXP1: Insight into its domain swapping and DNA bindingA genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagusIntegrative genomic profiling of human prostate cancerBrain-specific Foxp1 deletion impairs neuronal development and causes autistic-like behaviour.Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomyPUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma.Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinomaGATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4The significance of FOXP1 in diffuse large B-cell lymphoma.Update of human and mouse forkhead box (FOX) gene familiesVEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer.Male breast carcinoma: a clinicopathological and immunohistochemical characterization study.ICAD deficiency in human colon cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instability.FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells.Foxp1/2/4 regulate endochondral ossification as a suppresser complexNovel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.Novel DNA methylation profiles associated with key gene regulation and transcription pathways in blood and placenta of growth-restricted neonatesSupportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma.FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cellsFOXP1 forkhead transcription factor is associated with the pathogenesis of endometrial cancerGenome-wide association study identifies 14 novel risk alleles associated with basal cell carcinomaNon-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.Forkhead Box P family members at the crossroad between tolerance and immunity: a balancing act.The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.Expression of FOXP1 and Colorectal Cancer Prognosis.A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.High-incidence spontaneous tumors in JF1/Ms mice: relevance of hypomorphic germline mutation and subsequent promoter methylation of Ednrb.Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.BRCA1-mediated signaling pathways in ovarian carcinogenesis.
P2860
Q24304887-7CB8F886-38BF-422D-91D4-659A9A224678Q24655144-1FD89812-64C2-4E7F-A004-1928DC6987BAQ24656948-641EE42C-67DE-4F03-9964-7A141E227088Q27667284-2AE5536A-0421-4307-B5A0-38CD8AC55A19Q28943522-A456AA7B-4829-4DE8-9469-E5185A5008BAQ29619905-EAF26DB3-C25E-4B94-B716-31D53026CB7FQ30412243-2015E0D3-0C9F-4660-8A58-B57C4BD29CE7Q33417186-5B260F51-7EB1-485D-9A71-3145CB1C9D69Q33675855-1E36C246-BED0-4927-B20E-452EAADF497CQ33726112-D6313CBF-EDB6-4652-AC9B-938B1FB9FC06Q33789015-C00F8384-8F64-44F3-8058-10DE536F4B8CQ33911353-9608B71C-153C-4BFD-8F4B-76B210270D4BQ34047455-4C2CDD14-B30A-4ADA-BD20-F6C953151D04Q34127422-D233AABE-A26B-471A-BE37-6BD36818228FQ34373527-405454E4-D15C-4150-8D82-08C414F8E1E3Q34501947-D8F6AACE-40A0-4F90-8332-9804BAD2C386Q34603915-AEA058E3-0C89-4ED5-9463-C47F8DC263FCQ34611561-1D534FB4-B085-454F-98C7-92165C5E3100Q34675214-48C4EC0A-A1F6-4021-96C5-C2236748880DQ35125816-E6CBBFF8-69AC-4288-AD5A-C2426DC01E11Q35160562-9C81368D-5340-489B-96B9-536EA23ED03AQ35167200-45E0A1F2-D525-4844-BC0E-ADA84B2253FDQ35197356-EF8D5728-2760-4E50-9867-5266E593BC8AQ36214135-341DB79F-F420-4B30-9B81-31704BD15626Q36358569-13159C71-E646-4A00-A3FB-761E8E31185BQ36650112-D53D76C3-9426-40A8-B7B7-C81D09BE160BQ36753025-5CE30894-95B8-42B0-B221-BA899F5F830CQ36772183-5459DBFE-F9ED-4460-A41E-1BA41A534B27Q37097153-6561D84F-8C22-4418-9579-7FB09B06AA4FQ37191879-6D4DC936-9DB5-4535-AD7A-4E306AEA8ED8Q37458938-9B42610F-F88E-46A8-B697-E71CE239D7FFQ38124117-4AD105FE-1875-4C85-A280-545B4AE1785EQ38727975-0158F885-CFFF-4303-9622-EA593898288AQ38730434-2745126E-B80D-41C6-A0E3-00A368EBA40FQ38730495-C39FFA46-93EF-4240-81BB-8560EB5094E7Q38826119-1E0AB638-222D-4697-9FA2-E33172D2E872Q38893862-23D0199C-2377-44B1-B42D-F15D19901EE9Q39066757-87615781-4DB6-4791-B929-98C06991526BQ39136055-AFF9F493-5D5A-4A99-A956-0CAD9B93D2CDQ39480429-0B90E387-14CF-492B-88EA-B3AD9C6DD76C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
FOXP1: a potential therapeutic target in cancer.
@en
type
label
FOXP1: a potential therapeutic target in cancer.
@en
prefLabel
FOXP1: a potential therapeutic target in cancer.
@en
P2860
P1476
FOXP1: a potential therapeutic target in cancer
@en
P2093
Henry B Koon
Philip W Tucker
P2860
P304
P356
10.1517/14728222.11.7.955
P407
P577
2007-07-01T00:00:00Z